<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Sumitomo Heavy Industries, Ltd. 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=21059></link><description><![CDATA[Sumitomo Heavy Industries, Ltd. 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 02 May 2026 01:46:24 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2016/05/12_3554153577_20160526162947_7982200980.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Sumitomo Heavy Industries Announces Samsung Medical Center Starts Proton Therapy]]></title><link>https://www.newswire.co.kr/newsRead.php?no=827130</link><description><![CDATA[TOKYO--(Business Wire/Korea Newswire)--Sumitomo Heavy Industries, Ltd. (TOKYO:6302) (“SHI”) today announces that Samsung Medical Center (“SMC”) in Seoul, Korea has commenced proton therapy*1 and the opening ceremony was held on May 3, 2016.  The new proton therapy facility is equipped with cyclotron*2, which generates continuous and high intensity proton beam, and two rotating gantri...]]></description><pubDate>Thu, 26 May 2016 16:40:00 +0900</pubDate></item><item><title><![CDATA[스미토모중공업, 삼성의료원에서 양성자치료 시작 발표]]></title><link>https://www.newswire.co.kr/newsRead.php?no=827131</link><description><![CDATA[도쿄--(Business Wire/뉴스와이어)--스미토모중공업(Sumitomo Heavy Industries, Ltd.)(도쿄증권거래소: 6302)이 오늘 서울 삼성의료원이 2016년 5월 3일 개소식을 통해 양성자 치료(Proton Therapy)[1]를 시작했다고 발표했다.  새로운 양성자 치료설비는 끊임없이 고강도의 양성자 빔을 발생하는 사이클로트론(cyclotron)[2]과 2기의 회전식 갠트리(원통형 철제 구조물)를 장착하고 있다. 이 설비는 나중에 ...]]></description><image><url><![CDATA[https://file.newswire.co.kr/data/datafile2/thumb/2016/05/20160526163521_2964037027.jpg]]></url></image><pubDate>Thu, 26 May 2016 16:40:00 +0900</pubDate></item><item><title><![CDATA[Sumitomo Proton Therapy System Clears FDA 510(k)]]></title><link>https://www.newswire.co.kr/newsRead.php?no=726014</link><description><![CDATA[TOKYO--(Business Wire/Korea Newswire)--Sumitomo Heavy Industries, Ltd. (TOKYO:6302) announced today that it had received US FDA 510(k) clearance of its Proton Therapy System. It is the first 510(k) cleared medical device for Sumitomo.   Proton therapy is a form of radiation therapy, which employs proton beams to kill cancer cells with better dose distribution in comparison with conve...]]></description><image><url><![CDATA[https://file.newswire.co.kr/data/datafile2/thumb/2013/12/20131202115921_9388763868.jpg]]></url></image><pubDate>Mon, 02 Dec 2013 11:55:00 +0900</pubDate></item><item><title><![CDATA[스미토모 양성자 치료 시스템, FDA 510 (K) 승인]]></title><link>https://www.newswire.co.kr/newsRead.php?no=726015</link><description><![CDATA[도쿄--(Business Wire/뉴스와이어)--스미토모 중공업(Sumitomo Heavy Industries, Ltd., 도쿄증권거래소: 6302)은 오늘 자사의 양성자 치료 시스템 (Proton Therapy System)이 미국 식약청 (US FDA) 510 (K)승인을 받았다고 밝혔다. 스미토모로서는 처음으로 510 (K)승인을 받은 의료 기기이다.   양성자 치료는 기존의 엑스레이에 비해 더 나은 선량 분포를 통해 양성자 빔으로 암 세포를 죽이는 방사선 치료...]]></description><image><url><![CDATA[https://file.newswire.co.kr/data/datafile2/thumb/2013/12/20131202115935_9461921295.jpg]]></url></image><pubDate>Mon, 02 Dec 2013 11:55:00 +0900</pubDate></item></channel></rss>